Edmonton, Canada

B Gino Fallone

USPTO Granted Patents = 10 

 


Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 125(Granted Patents)


Location History:

  • Alberta, CA (2011 - 2016)
  • Edmonton, CA (2015 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: B Gino Fallone: Innovator in Radiotherapy Technology

Introduction

B Gino Fallone is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of radiotherapy, particularly in the integration of magnetic resonance imaging (MRI) with radiotherapy systems. With a total of 10 patents to his name, Fallone's work is at the forefront of medical technology innovation.

Latest Patents

Among his latest patents is the "Real-time MRI-PET-guided radiotherapy system with dose-deposition verification." This advanced system is designed to determine in vivo dose deposition of a radiotherapy treatment beam. It includes a bi-planar MRI apparatus with spaced magnets, a treatment beam source, and a PET detector that captures data on the treatment beam's impact on the patient. Another notable patent is the "Peripheral tumour treatment," which describes an MR-radiotherapy hybrid system. This system features an MRI apparatus, a radiation source, and a motorized treatment support that ensures patient safety during treatment.

Career Highlights

B Gino Fallone is affiliated with Alberta Health Services, where he continues to develop innovative solutions in the field of radiotherapy. His work has been instrumental in enhancing the precision and effectiveness of cancer treatments.

Collaborations

Fallone collaborates with talented professionals in his field, including colleagues Brad Murray and Marco Carlone. Their combined expertise contributes to the advancement of radiotherapy technologies.

Conclusion

B Gino Fallone's contributions to radiotherapy technology exemplify the impact of innovation in healthcare. His patents and ongoing work continue to shape the future of cancer treatment, improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…